ID

20158

Descripción

A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00419250

Link

https://clinicaltrials.gov/show/NCT00419250

Palabras clave

Versiones (1)
  1. 8/2/17 8/2/17 -
Subido en

8 de febrero de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Chronic Lymphocytic Leukemia NCT00419250

Inglés

Eligibility Chronic Lymphocytic Leukemia NCT00419250

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
documented diagnosis of b-cell cll that has relapsed after or is refractory to at least one prior regimen. the prior regimen(s) must have included an alkylating agent and fludarabine (used in combination or separately)
Descripción

Regimen Quantity Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphoid Leukemia | Chronic lymphocytic leukaemia refractory | Alkylating Agents | fludarabine | Combined Modality Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0040808
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0023434
UMLS CUI [2]
C0854802
UMLS CUI [3]
C0278791
UMLS CUI [4]
C0002073
UMLS CUI [5]
C0059985
UMLS CUI [6]
C0009429
ecog < or = 2
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
willing to agree to follow the pregnancy precautions.
Descripción

Pregnancy Precaution Compliance behavior

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C1882442
UMLS CUI [1,3]
C1321605
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or nursing women
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
systemic treatment for b-cell cll within 28 days of study start
Descripción

systemic therapy Chronic Lymphocytic Leukemia

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C0023434
central nervous system involvement
Descripción

Central Nervous System Involvement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4050309
history of renal failure requiring dialysis
Descripción

Kidney Failure Requirement Dialysis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0035078
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0011946
prior treatment with lenalidomide
Descripción

lenalidomide

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1144149
alemtuzumab therapy within 56 days of initiating lenalidomide treatment
Descripción

alemtuzumab | lenalidomide

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0383429
UMLS CUI [2]
C1144149
anc < 1000 / ul
Descripción

Absolute neutrophil count

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0948762
platelet count < 50,000 / ul
Descripción

Platelet Count measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032181
calculated creatinine clearance < 60 ml/min (cockroft-gault method)
Descripción

Estimation of creatinine clearance by Cockcroft-Gault formula

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2711451
ast or alt > 3.0 x upper limit of normal
Descripción

Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
serum total bilirubin > 2.0 mg/dl
Descripción

Serum total bilirubin measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1278039
neuropathy > or = grade 2
Descripción

Neuropathy CTCAE Grades

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0442874
UMLS CUI [1,2]
C1516728
uncontrolled autoimmune hemolytic anemia or thrombocytopenia
Descripción

Autoimmune hemolytic anemia Uncontrolled | Autoimmune thrombocytopenia Uncontrolled

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0002880
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0242584
UMLS CUI [2,2]
C0205318
richter's transformation (active)
Descripción

Richter's syndrome

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0349631
Volver a la parte superior de la página

Similar models

Eligibility Chronic Lymphocytic Leukemia NCT00419250

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Regimen Quantity Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphoid Leukemia | Chronic lymphocytic leukaemia refractory | Alkylating Agents | fludarabine | Combined Modality Therapy
Item
documented diagnosis of b-cell cll that has relapsed after or is refractory to at least one prior regimen. the prior regimen(s) must have included an alkylating agent and fludarabine (used in combination or separately)
boolean
C0040808 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0023434 (UMLS CUI [1,3])
C0854802 (UMLS CUI [2])
C0278791 (UMLS CUI [3])
C0002073 (UMLS CUI [4])
C0059985 (UMLS CUI [5])
C0009429 (UMLS CUI [6])
ECOG performance status
Item
ecog < or = 2
boolean
C1520224 (UMLS CUI [1])
Pregnancy Precaution Compliance behavior
Item
willing to agree to follow the pregnancy precautions.
boolean
C0032961 (UMLS CUI [1,1])
C1882442 (UMLS CUI [1,2])
C1321605 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
pregnant or nursing women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
systemic therapy Chronic Lymphocytic Leukemia
Item
systemic treatment for b-cell cll within 28 days of study start
boolean
C1515119 (UMLS CUI [1,1])
C0023434 (UMLS CUI [1,2])
Central Nervous System Involvement
Item
central nervous system involvement
boolean
C4050309 (UMLS CUI [1])
Kidney Failure Requirement Dialysis
Item
history of renal failure requiring dialysis
boolean
C0035078 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0011946 (UMLS CUI [1,3])
lenalidomide
Item
prior treatment with lenalidomide
boolean
C1144149 (UMLS CUI [1])
alemtuzumab | lenalidomide
Item
alemtuzumab therapy within 56 days of initiating lenalidomide treatment
boolean
C0383429 (UMLS CUI [1])
C1144149 (UMLS CUI [2])
Absolute neutrophil count
Item
anc < 1000 / ul
boolean
C0948762 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count < 50,000 / ul
boolean
C0032181 (UMLS CUI [1])
Estimation of creatinine clearance by Cockcroft-Gault formula
Item
calculated creatinine clearance < 60 ml/min (cockroft-gault method)
boolean
C2711451 (UMLS CUI [1])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
ast or alt > 3.0 x upper limit of normal
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
Serum total bilirubin measurement
Item
serum total bilirubin > 2.0 mg/dl
boolean
C1278039 (UMLS CUI [1])
Neuropathy CTCAE Grades
Item
neuropathy > or = grade 2
boolean
C0442874 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Autoimmune hemolytic anemia Uncontrolled | Autoimmune thrombocytopenia Uncontrolled
Item
uncontrolled autoimmune hemolytic anemia or thrombocytopenia
boolean
C0002880 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0242584 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Richter's syndrome
Item
richter's transformation (active)
boolean
C0349631 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial